TechNavio recognizes the following companies as the key players in the Global Parkinson’s Disease Market: as GlaxoSmithKline plc, Novartis AG, Orion Corp., and Teva Pharmaceuticals Industries Ltd.
Commenting on the report, an analyst from TechNavio’s team said: “Vaccine development is undergoing significant advancements in the market; special focus is given to neurodegenerative diseases such as Parkinson’s disease. As the drugs used to treat patients with Parkinson’s have only been able to address the symptoms, a huge unmet need lies in this region. There isn’t a single drug available that can modify the course of the disease. AFFiRiS AG, an Australian pharmaceutical company, is involved in the first-ever Phase I clinical development trial for Parkinson’s disease (PD01A). The vaccine targets the protein alpha-Synuclein, which is responsible for the onset of the disease. PD01A is expected to encourage disease modifying effects and not symptomatic relief.”
According to the report, one of the main drivers propelling the growth of the market is the steadily growing aging population worldwide. The increasing aging population is contributing to the growth of the market. The number of patients suffering from Parkinson’s disease is increasing owing to the increasing aging population both in the developing and developed nations.
Further, the report states that one of the major challenges faced by the market is the weak pipeline landscape. Most products in the pipeline lack molecules which can potentially achieve blockbuster status in the near future.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Merck Serono S.A, Newron Pharmaceuticals SpA, Acadia Pharmaceuticals Inc., Avicena Group Inc., Impax Laboratories Inc., and Solvay Pharmaceuticals Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/report/global-parkinsons-disease-market-2012-2016
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare-chemicals-food-retail
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report -Global Parkinson's Disease Market 2012-2016
